rs377345813
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2
The ENST00000381529.9(CSF2RA):c.728_729insGTCGGTGAGACAGAAAG(p.Tyr243ValfsTer16) variant causes a frameshift, stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,613,822 control chromosomes in the GnomAD database, including 70 homozygotes. There are 1,603 hemizygotes in GnomAD. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000381529.9 frameshift, stop_gained
Scores
Clinical Significance
Conservation
Publications
- surfactant metabolism dysfunction, pulmonary, 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hereditary pulmonary alveolar proteinosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0114 AC: 1735AN: 152148Hom.: 30 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00313 AC: 785AN: 251082 AF XY: 0.00217 show subpopulations
GnomAD4 exome AF: 0.00124 AC: 1814AN: 1461556Hom.: 37 Cov.: 32 AF XY: 0.00106 AC XY: 772AN XY: 727098 show subpopulations
GnomAD4 genome AF: 0.0115 AC: 1753AN: 152266Hom.: 33 Cov.: 32 AF XY: 0.0112 AC XY: 831AN XY: 74436 show subpopulations
ClinVar
Submissions by phenotype
not specified Benign:2
c.774_780+10dup in intron 9 of CSF2RA: This variant is not expected to have clin ical significance because it has been identified in 4.1% (976/24018) of African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinsti tute.org; dbSNP rs770360117), including 19 homozygous individuals. ACMG/AMP Crit eria applied: BA1. -
- -
Surfactant metabolism dysfunction, pulmonary, 4 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at